Skip to main content
SpringerLink
Log in

Angiotensin Converting Enzyme Inhibitors and Restenosis: Let's Stop Teasing Ourselves

  • Editorial Board
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Teo KK, Burton JR, Buller CE, et al. Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/ Enalapril Atherosclerosis Trial (SCAT). Circulation 2000; 102: 1748-1754.

    PubMed  Google Scholar 

  2. Cashin-Hemphill L, Holmvang G, Chan RC, Pitt B, Dinsmore RE, Lees RS. For the QUIET Investigators. Angiotensin-converting enyme inhibition as antiatherosclerotic therapy: No answer yet. Am J Cardiol 1999; 83: 43-47.

    PubMed  Google Scholar 

  3. Cashin-Hemphill L, Dinsmore RE, Chan RC, et al. Atherosclerosis progression in subjects with and without post-angioplasty restenosis in QUIET. J Am Coll Cardiol 1997; 29:418A.

  4. Cashin Hemphill L, Dinsmore RE, Chan RC, et al. LDL cholesterol and angiographic progression in the QUIET Trial. J Am Coll Cardiol 1997; 29:85A.

  5. Pitt B, O'Neill B, Feldman R, et al. For the QUIET Study Group. The Quinapril Ischemic Event Trial (QUIET): Evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and peserved left ventricular function. Am J Cardiol 2001; 87: 1058-1063.

    PubMed  Google Scholar 

  6. Lonn EM, Yusuf S, Dzavik V, et al. Effects of ramipril and vitamin E on atherosclerosis-the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamine E (SECURE). Circulation 2001; 103: 919-925.

    PubMed  Google Scholar 

  7. MacMahon S, Sharpe N, Gamble G, et al. Randomized, placebo-controlled trial of the angiotensin-converting enzye inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. J Am Coll Cardiol 2000; 36:444.

  8. The Heart Outcome Preention Evaluation Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in hig-risk patients. N Engl J Med 2000; 342: 145-153.

    Google Scholar 

  9. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebocontrolled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis(MERCATOR) Study Group. Circulation 1992; 86: 100-110.

  10. Faxon DP. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research trial with Cilazapril after Angioplasty to prevent Transluminal coronary Obstruction and Restenosis (MARCATOR) Study Group. J Am Coll Cardiol 1995; 25: 362-369.

    PubMed  Google Scholar 

  11. Desmet W, Vrolix M, DeScheerder I, Van Lierde J, Willems JL, Piessens J. Angiotensin-converting enzyme inhibitio with fosinopril sodium in the prevention of restenosis after coronary angioplasty. Circulation 1994; 89: 385-392.

    PubMed  Google Scholar 

  12. Okamura A, Ohishi M, Rakugi H, et al. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty. Angiology 1999; 50: 811-822.

    PubMed  Google Scholar 

  13. Kondo J, Sone T, Tsuboi H, et al. Effect of quinapril on intimal hyperplasia after coronary stenting assessed by intravascular ultrsound. Am J Cardiol 2001; 87: 443-445.

    PubMed  Google Scholar 

  14. Mancini GBJ. Long-term use of angiotensin-converting enzyme inhibitor to modigy endothelial dysfunction: A review of clinical investigations. Clin Invest Med 2000; 23: 144-161.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of British Columbia; Vancouver Hospital and Health Sciences Center, Vancouver, BC, Canada

    G.B. John Mancini

Authors
  1. G.B. John Mancini
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

John Mancini, G. Angiotensin Converting Enzyme Inhibitors and Restenosis: Let's Stop Teasing Ourselves. Cardiovasc Drugs Ther 15, 293–295 (2001). https://doi.org/10.1023/A:1012702928239

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012702928239

Search

Navigation